↓ Skip to main content

Impaired iron homeostasis in Parkinson's disease.

Overview of attention for book
Cover of 'Impaired iron homeostasis in Parkinson's disease.'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 1 The L -DOPA story revisited. Further surprises to be expected?
  3. Altmetric Badge
    Chapter 2 The enigma of cell death in neurodegenerative disorders
  4. Altmetric Badge
    Chapter 3 Impaired iron homeostasis in Parkinson’s disease
  5. Altmetric Badge
    Chapter 4 The molecular mechanism of dopamine-induced apoptosis: identification and characterization of genes that mediate dopamine toxicity
  6. Altmetric Badge
    Chapter 5 Glyceraldehyde-3-phosphate dehydrogenase in neurodegeneration and apoptosis signaling
  7. Altmetric Badge
    Chapter 6 Importance of familial Parkinson’s disease and parkinsonism to the understanding of nigral degeneration in sporadic Parkinson’s disease
  8. Altmetric Badge
    Chapter 7 cDNA microarray to study gene expression of dopaminergic neurodegeneration and neuroprotection in MPTP and 6-hydroxydopamine models: implications for idiopathic Parkinson’s disease
  9. Altmetric Badge
    Chapter 8 Monitoring neuroprotection and restorative therapies in Parkinson’s disease with PET
  10. Altmetric Badge
    Chapter 9 Common properties for propargylamines of enhancing superoxide dismutase and catalase activities in the dopaminergic system in the rat: implications for the life prolonging effect of (–)deprenyl
  11. Altmetric Badge
    Chapter 10 TV3326, a novel neuroprotective drug with cholinesterase and monoamine oxidase inhibitory activities for the treatment of Alzheimer's disease.
  12. Altmetric Badge
    Chapter 11 Neurotoxins induce apoptosis in dopamine neurons: protection by N-propargylamine-1(R)- and (S)-aminoindan, rasagiline and TV1022
  13. Altmetric Badge
    Chapter 12 Homocysteine and alcoholism
  14. Altmetric Badge
    Chapter 13 Neurorescuing effects of the GAPDH ligand CGP 3466B.
  15. Altmetric Badge
    Chapter 14 The neuroprotective effects of CGP 3466B in the best in vivo model of Parkinson's disease, the bilaterally MPTP-treated rhesus monkey.
  16. Altmetric Badge
    Chapter 15 Neurotrophic effects of central nicotinic receptor activation
  17. Altmetric Badge
    Chapter 16 Regulation of neuronal cell death and differentiation by NGF and IAP family members
  18. Altmetric Badge
    Chapter 17 Insulin-like growth factor-1 (IGF-1): a neuroprotective trophic factor acting via the Akt kinase pathway
  19. Altmetric Badge
    Chapter 18 GDF-15/MIC-1 a novel member of the TGF-ß superfamily
  20. Altmetric Badge
    Chapter 19 Changes in cytokines and neurotrophins in Parkinson’s disease
  21. Altmetric Badge
    Chapter 20 Psychiatric complications in Parkinson’s disease
  22. Altmetric Badge
    Chapter 21 Dementia with Lewy bodies: prevalence, clinical spectrum and natural history
  23. Altmetric Badge
    Chapter 22 Neuronal degeneration and reorganization: a mutual principle in pathological and in healthy interactions of limbic and prefrontal circuits
  24. Altmetric Badge
    Chapter 23 Depression in alpha-synucleinopathies: prevalence, pathophysiology and treatment
  25. Altmetric Badge
    Chapter 24 The serotonin transporter in Alzheimer’s and Parkinson’s disease
  26. Altmetric Badge
    Chapter 25 Immunopathogenic and clinical relevance of antibodies against myelin oligodendrocyte glycoprotein (MOG) in Multiple Sclerosis
  27. Altmetric Badge
    Chapter 26 Lessons from studies of antigen-specific T cell responses in Multiple Sclerosis
  28. Altmetric Badge
    Chapter 27 Glutamate excitotoxicity — a mechanism for axonal damage and oligodendrocyte death in Multiple Sclerosis?
  29. Altmetric Badge
    Chapter 28 Evidence for enhanced neuro-inflammatory processes in neurodegenerative diseases and the action of nitrones as potential therapeutics
Overall attention for this book and its chapters
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (83rd percentile)
  • High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

policy
1 policy source
wikipedia
4 Wikipedia pages

Citations

dimensions_citation
6 Dimensions